Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
agmatine alpha-2c adrenergic receptor small molecule NA drugbank Diabetes Mellitus[MeSHID:D003920]
Small Fiber Neuropathy[MeSHID:D000071075]
Neuroprotection[MeSHID:D000066829]
Glaucoma[MeSHID:D005901]
Diagnosis[MeSHID:D003933]
Epilepsy[MeSHID:D004827]
Kidney[MeSHID:D007668]
Anxiety Disorders[MeSHID:D001008]
Blind Vision[MeSHID:D001766]
Mental Depression[MeSHID:D003863]
Cognition[MeSHID:D003071]
Schizophrenia[MeSHID:D012559]
Depressive disorder[MeSHID:D003866]
Neuralgia[MeSHID:D009437]
Traumatic injury[MeSHID:D014947]
Cerebrovascular accident[MeSHID:D020521]
Anxiety[MeSHID:D001007]
NA experimental agonist
agmatine acid-sensing ion channel 3 small molecule NA drugbank , DGIDB Diabetes Mellitus[MeSHID:D003920]
Small Fiber Neuropathy[MeSHID:D000071075]
Neuroprotection[MeSHID:D000066829]
Glaucoma[MeSHID:D005901]
Diagnosis[MeSHID:D003933]
Epilepsy[MeSHID:D004827]
Kidney[MeSHID:D007668]
Anxiety Disorders[MeSHID:D001008]
Blind Vision[MeSHID:D001766]
Mental Depression[MeSHID:D003863]
Cognition[MeSHID:D003071]
Schizophrenia[MeSHID:D012559]
Depressive disorder[MeSHID:D003866]
Neuralgia[MeSHID:D009437]
Traumatic injury[MeSHID:D014947]
Cerebrovascular accident[MeSHID:D020521]
Anxiety[MeSHID:D001007]
15.91 experimental agonist,activator
agmatine voltage-dependent n-type calcium channel subunit alpha-1b small molecule NA drugbank Diabetes Mellitus[MeSHID:D003920]
Small Fiber Neuropathy[MeSHID:D000071075]
Neuroprotection[MeSHID:D000066829]
Glaucoma[MeSHID:D005901]
Diagnosis[MeSHID:D003933]
Epilepsy[MeSHID:D004827]
Kidney[MeSHID:D007668]
Anxiety Disorders[MeSHID:D001008]
Blind Vision[MeSHID:D001766]
Mental Depression[MeSHID:D003863]
Cognition[MeSHID:D003071]
Schizophrenia[MeSHID:D012559]
Depressive disorder[MeSHID:D003866]
Neuralgia[MeSHID:D009437]
Traumatic injury[MeSHID:D014947]
Cerebrovascular accident[MeSHID:D020521]
Anxiety[MeSHID:D001007]
NA experimental antagonist
agmatine acetylcholine receptor subunit alpha small molecule NA drugbank Diabetes Mellitus[MeSHID:D003920]
Small Fiber Neuropathy[MeSHID:D000071075]
Neuroprotection[MeSHID:D000066829]
Glaucoma[MeSHID:D005901]
Diagnosis[MeSHID:D003933]
Epilepsy[MeSHID:D004827]
Kidney[MeSHID:D007668]
Anxiety Disorders[MeSHID:D001008]
Blind Vision[MeSHID:D001766]
Mental Depression[MeSHID:D003863]
Cognition[MeSHID:D003071]
Schizophrenia[MeSHID:D012559]
Depressive disorder[MeSHID:D003866]
Neuralgia[MeSHID:D009437]
Traumatic injury[MeSHID:D014947]
Cerebrovascular accident[MeSHID:D020521]
Anxiety[MeSHID:D001007]
NA experimental antagonist
agmatine glutamate receptor ionotropic, nmda 1 small molecule NA drugbank Diabetes Mellitus[MeSHID:D003920]
Small Fiber Neuropathy[MeSHID:D000071075]
Neuroprotection[MeSHID:D000066829]
Glaucoma[MeSHID:D005901]
Diagnosis[MeSHID:D003933]
Epilepsy[MeSHID:D004827]
Kidney[MeSHID:D007668]
Anxiety Disorders[MeSHID:D001008]
Blind Vision[MeSHID:D001766]
Mental Depression[MeSHID:D003863]
Cognition[MeSHID:D003071]
Schizophrenia[MeSHID:D012559]
Depressive disorder[MeSHID:D003866]
Neuralgia[MeSHID:D009437]
Traumatic injury[MeSHID:D014947]
Cerebrovascular accident[MeSHID:D020521]
Anxiety[MeSHID:D001007]
NA experimental antagonist
agmatine atp-sensitive inward rectifier potassium channel 1 small molecule NA drugbank Diabetes Mellitus[MeSHID:D003920]
Small Fiber Neuropathy[MeSHID:D000071075]
Neuroprotection[MeSHID:D000066829]
Glaucoma[MeSHID:D005901]
Diagnosis[MeSHID:D003933]
Epilepsy[MeSHID:D004827]
Kidney[MeSHID:D007668]
Anxiety Disorders[MeSHID:D001008]
Blind Vision[MeSHID:D001766]
Mental Depression[MeSHID:D003863]
Cognition[MeSHID:D003071]
Schizophrenia[MeSHID:D012559]
Depressive disorder[MeSHID:D003866]
Neuralgia[MeSHID:D009437]
Traumatic injury[MeSHID:D014947]
Cerebrovascular accident[MeSHID:D020521]
Anxiety[MeSHID:D001007]
NA experimental antagonist
agmatine nischarin small molecule NA drugbank Diabetes Mellitus[MeSHID:D003920]
Small Fiber Neuropathy[MeSHID:D000071075]
Neuroprotection[MeSHID:D000066829]
Glaucoma[MeSHID:D005901]
Diagnosis[MeSHID:D003933]
Epilepsy[MeSHID:D004827]
Kidney[MeSHID:D007668]
Anxiety Disorders[MeSHID:D001008]
Blind Vision[MeSHID:D001766]
Mental Depression[MeSHID:D003863]
Cognition[MeSHID:D003071]
Schizophrenia[MeSHID:D012559]
Depressive disorder[MeSHID:D003866]
Neuralgia[MeSHID:D009437]
Traumatic injury[MeSHID:D014947]
Cerebrovascular accident[MeSHID:D020521]
Anxiety[MeSHID:D001007]
NA experimental agonist
click here to return to the previous page